Cargando…

Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant

BACKGROUND & OBJECTIVES: Tuberculosis is a major health problem in India, and the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains of Mycobacterium tuberculosis (Mtb) has further complicated the situation. Though several studies characterizing drug sensitive an...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Amit, Gopinath, Krishnamoorthy, Sharma, Prashant, Bisht, Deepa, Sharma, Pawan, Singh, Niti, Singh, Sarman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405938/
https://www.ncbi.nlm.nih.gov/pubmed/25857493
_version_ 1782367689124085760
author Singh, Amit
Gopinath, Krishnamoorthy
Sharma, Prashant
Bisht, Deepa
Sharma, Pawan
Singh, Niti
Singh, Sarman
author_facet Singh, Amit
Gopinath, Krishnamoorthy
Sharma, Prashant
Bisht, Deepa
Sharma, Pawan
Singh, Niti
Singh, Sarman
author_sort Singh, Amit
collection PubMed
description BACKGROUND & OBJECTIVES: Tuberculosis is a major health problem in India, and the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains of Mycobacterium tuberculosis (Mtb) has further complicated the situation. Though several studies characterizing drug sensitive and drug resistant strains are available in literature, almost all studies are done on unrelated strains. Therefore, the objective of this study was to compare the proteomic data of four sequential isolates of Mtb from a single patient who developed MDR-TB during the course of anti-tuberculosis therapy (ATT). METHODS: In this study, using two-dimensional (2D) gel electrophoresis and MALDI-TOF mass spectrometry, we compared and analyzed the cell lysate proteins of Mtb sequential clinical isolates from a patient undergoing anti-TB treatment. The mRNA expression levels of selected identified proteins were determined by quantitative real-time polymerase chain reaction (qRT-PCR). RESULTS: The genotypes of all four isolates remained homologous, indicating no re-infection. The initial isolate (before treatment) was sensitive to all first-line drugs, but the consecutive isolates were found to be resistant to isoniazid (INH) and rifampicin (RIF) and developed mutations in the katG, inhA and rpoB. The intensities of 27 protein spots were found to be consistently overexpressed in INH and RIF resistant isolates. The most prominent and overexpressed proteins found during the development of drug resistance were GarA (Rv1827), wag31 (Rv2145c), Rv1437 and Rv2970c. INTERPRETATION & CONCLUSIONS: This preliminary proteomic study provides an insight about the proteins that are upregulated during drug resistance development. These upregulated proteins, identified here, could prove useful as immunodiagnostic and possibly drug resistant markers in future. However, more studies are required to confirm these findings.
format Online
Article
Text
id pubmed-4405938
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-44059382015-05-06 Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant Singh, Amit Gopinath, Krishnamoorthy Sharma, Prashant Bisht, Deepa Sharma, Pawan Singh, Niti Singh, Sarman Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Tuberculosis is a major health problem in India, and the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains of Mycobacterium tuberculosis (Mtb) has further complicated the situation. Though several studies characterizing drug sensitive and drug resistant strains are available in literature, almost all studies are done on unrelated strains. Therefore, the objective of this study was to compare the proteomic data of four sequential isolates of Mtb from a single patient who developed MDR-TB during the course of anti-tuberculosis therapy (ATT). METHODS: In this study, using two-dimensional (2D) gel electrophoresis and MALDI-TOF mass spectrometry, we compared and analyzed the cell lysate proteins of Mtb sequential clinical isolates from a patient undergoing anti-TB treatment. The mRNA expression levels of selected identified proteins were determined by quantitative real-time polymerase chain reaction (qRT-PCR). RESULTS: The genotypes of all four isolates remained homologous, indicating no re-infection. The initial isolate (before treatment) was sensitive to all first-line drugs, but the consecutive isolates were found to be resistant to isoniazid (INH) and rifampicin (RIF) and developed mutations in the katG, inhA and rpoB. The intensities of 27 protein spots were found to be consistently overexpressed in INH and RIF resistant isolates. The most prominent and overexpressed proteins found during the development of drug resistance were GarA (Rv1827), wag31 (Rv2145c), Rv1437 and Rv2970c. INTERPRETATION & CONCLUSIONS: This preliminary proteomic study provides an insight about the proteins that are upregulated during drug resistance development. These upregulated proteins, identified here, could prove useful as immunodiagnostic and possibly drug resistant markers in future. However, more studies are required to confirm these findings. Medknow Publications & Media Pvt Ltd 2015-01 /pmc/articles/PMC4405938/ /pubmed/25857493 Text en Copyright: © Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Singh, Amit
Gopinath, Krishnamoorthy
Sharma, Prashant
Bisht, Deepa
Sharma, Pawan
Singh, Niti
Singh, Sarman
Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant
title Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant
title_full Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant
title_fullStr Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant
title_full_unstemmed Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant
title_short Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant
title_sort comparative proteomic analysis of sequential isolates of mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405938/
https://www.ncbi.nlm.nih.gov/pubmed/25857493
work_keys_str_mv AT singhamit comparativeproteomicanalysisofsequentialisolatesofmycobacteriumtuberculosisfromapatientwithpulmonarytuberculosisturningfromdrugsensitivetomultidrugresistant
AT gopinathkrishnamoorthy comparativeproteomicanalysisofsequentialisolatesofmycobacteriumtuberculosisfromapatientwithpulmonarytuberculosisturningfromdrugsensitivetomultidrugresistant
AT sharmaprashant comparativeproteomicanalysisofsequentialisolatesofmycobacteriumtuberculosisfromapatientwithpulmonarytuberculosisturningfromdrugsensitivetomultidrugresistant
AT bishtdeepa comparativeproteomicanalysisofsequentialisolatesofmycobacteriumtuberculosisfromapatientwithpulmonarytuberculosisturningfromdrugsensitivetomultidrugresistant
AT sharmapawan comparativeproteomicanalysisofsequentialisolatesofmycobacteriumtuberculosisfromapatientwithpulmonarytuberculosisturningfromdrugsensitivetomultidrugresistant
AT singhniti comparativeproteomicanalysisofsequentialisolatesofmycobacteriumtuberculosisfromapatientwithpulmonarytuberculosisturningfromdrugsensitivetomultidrugresistant
AT singhsarman comparativeproteomicanalysisofsequentialisolatesofmycobacteriumtuberculosisfromapatientwithpulmonarytuberculosisturningfromdrugsensitivetomultidrugresistant